Sensory Morbidity Following Breast Surgery
1 other identifier
observational
290
1 country
1
Brief Summary
The goal of the study is measure breast sensations after breast surgery. The results of this study will help surgeons better understand breast sensations and may improve the way surgery is done.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2008
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2008
CompletedFirst Submitted
Initial submission to the registry
February 20, 2008
CompletedFirst Posted
Study publicly available on registry
February 29, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2014
CompletedJanuary 16, 2014
January 1, 2014
5.9 years
February 20, 2008
January 14, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To evaluate the prevalence, severity and level of distress of subjective breast sensations following mastectomy and postmastectomy reconstruction.
conclusion of the study
Secondary Outcomes (1)
To compare sensory morbidity following three types of breast surgery: tissue expander/implant breast reconstruction, autogenous tissue reconstruction, and no reconstruction.
conclusion of the study
Study Arms (3)
1
autogenous tissue breast reconstruction
2
tissue expander/implant breast reconstruction
3
mastectomy alone
Interventions
Patients will be evaluated at one time point using the Breast Sensation Assessment Score (BSAS©), the SF-36 Health Survey, the MSKCC BREAST Q, the Brief Pain Inventory, the Hopwood Body Image Scale, the Profile of Mood States - Brief Version (POMS - BRF), and the 'Patient Demographic and Treatment Information Form'
Eligibility Criteria
MSKCC clinics
You may qualify if:
- The Samples used will be derived from three cohorts below and will only include patients who have completed mastectomy or reconstruction within 1-5 years of enrollment.
- Patients who have undergone immediate, two-stage expander/implant postmastectomy reconstruction
- Patients who have undergone immediate, autogenous tissue flap reconstruction following mastectomy
- Patients who have undergone mastectomy alone
- Patients at least 21 years of age
- Patients who completed mastectomy ± immediate post-mastectomy reconstruction at least one year but no longer than five years prior to study entry
You may not qualify if:
- Patients who have had any of the following:
- delayed reconstruction (no reconstruction at time of surgery) combined autogenous tissue/implant breast reconstruction, and/or
- Patients who have a pre-surgical history of complex regional pain syndrome
- Patients who have had radiation therapy
- Patients who have had a local recurrence
- Patients who do not speak the English language (validated translations of key questionnaires are not available).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrea Pusic, MD
Memorial Sloan Kettering Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 20, 2008
First Posted
February 29, 2008
Study Start
February 1, 2008
Primary Completion
January 1, 2014
Study Completion
January 1, 2014
Last Updated
January 16, 2014
Record last verified: 2014-01